Our study showed a significant decrease in CDC25C, p-CDC25C, CDK2, Cyclin B1, and c-Myc, along with an increase in P53, P21Cip1, and P27Kip1 in BPH-1 cells when treated with TMJ-12. The gene discussed is TP53; the disease is benign prostatic hyperplasia.